ALFALFA - MEDICAGO SATIVA

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

This monograph is intended to serve as a guide to industry for the preparation of Product Licence Applications (PLAs) and labels for natural health product market authorization. It is not intended to be a comprehensive review of the medicinal ingredient.

Notes

Date

June 3, 2019

Proper name(s), Common name(s), Source material(s)

Table 1. Proper name(s), Common name(s), Source material(s)
Proper name(s) Common name(s) Source material(s)
Proper name(s) Part(s) Preparation
Medicago sativa
  • Alfalfa
  • Lucerne
Medicago sativa
  • Herb top
  • Leaf
Dried

References: Proper name: USDA 2019; Common names: BHP 1996, Meyer 1993; Source materials: Boon and Smith 2004, BHP 1996.

Route of Administration

Oral

Dosage Form(s)

This monograph excludes foods or food-like dosage forms as indicated in the Compendium of Monographs Guidance Document.

Acceptable dosage forms for any age category listed in this monograph for the specified route of administration are listed in the Compendium of Monographs Guidance Document.

Use(s) or Purpose(s)

Traditionally used in Herbal Medicine as a nutritive tonic (Meyer 1993; BHP 1983).

Note

Claims for traditional use must include the term "Herbal Medicine", "Traditional Chinese Medicine", or "Ayurveda".

Dose(s)

Subpopulation(s)

Adults 18 years and older

Quantity(ies)

Methods of preparation: Dry, Powder, Non-Standardised Extracts (Dry extract, Tincture, Fluid extract, Decoction, Infusion)

9 - 30 grams of dried herb top/leaf, per day (Mills 1985; BHP 1983)

Direction(s) for use

No statement required.

Duration(s) of Use

No statement required.

Risk Information

Caution(s) and warning(s)

Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking blood thinners, birth control medication or undergoing hormone replacement therapy (HRT) (Barnes et al. 2007; Boon and Smith 2004; Brinker 2001).

Contraindication(s)

Do not use this product if you are pregnant, breastfeeding or have a history of systemic lupus erythematosus (Barnes et al. 2007; Boon and Smith 2004; Brinker 2001).

Known adverse reaction(s)

No statement required.

Non-medicinal ingredients

Must be chosen from the current Natural Health Products Ingredients Database (NHPID) and must meet the limitations outlined in the database.

Storage conditions

No statement required.

Specifications

References Cited

References Reviewed